COVID-19: Ophthalmic prophylactic and therapeutic measures.
作者信息
Waikar Shrikant, Oli Avadhesh
机构信息
Department of Ophthalmology, Institute of Naval Medicine, Indian Naval Hospital Ship Asvini, Near RC Church, Colaba, Mumbai, Maharashtra, India.
出版信息
Indian J Ophthalmol. 2020 Jun;68(6):1223-1224. doi: 10.4103/ijo.IJO_883_20.
Abstract
摘要
相似文献
1
COVID-19: Ophthalmic prophylactic and therapeutic measures.
Indian J Ophthalmol. 2020 Jun;68(6):1223-1224. doi: 10.4103/ijo.IJO_883_20.
2
Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV.
Graefes Arch Clin Exp Ophthalmol. 2020 Nov;258(11):2563-2565. doi: 10.1007/s00417-020-04752-2. Epub 2020 May 20.
3
Preventing intrahospital transmission of COVID-19: Experience from the University Hospital Zurich in Switzerland.
S Afr Med J. 2020 Jun 25;110(8):709-710.
4
0.5% povidone iodine irrigation in otorhinolaryngology surgical practice during COVID 19 pandemic.
Am J Otolaryngol. 2020 Nov-Dec;41(6):102687. doi: 10.1016/j.amjoto.2020.102687. Epub 2020 Aug 19.
5
Masks and Coronavirus Disease 2019 (COVID-19).
JAMA. 2020 May 26;323(20):2103. doi: 10.1001/jama.2020.6437.
6
Stopping the Spread of COVID-19.
JAMA. 2020 Apr 21;323(15):1516. doi: 10.1001/jama.2020.4269.
7
Use of oral antiseptics for SARS-CoV-2 infection.
Med Clin (Barc). 2020 Nov 13;155(9):416-417. doi: 10.1016/j.medcli.2020.07.014. Epub 2020 Jul 27.
8
Use of facemasks during the COVID-19 pandemic.
Lancet Respir Med. 2020 Oct;8(10):954-955. doi: 10.1016/S2213-2600(20)30352-0. Epub 2020 Aug 3.
9
COVID-19 and the history of antiseptic surgery: how to tackle these little beasts.
Hong Kong Med J. 2020 Jun;26(3):258-259. doi: 10.12809/hkmj208617. Epub 2020 Jun 3.
10
Universal Masking in Hospitals in the Covid-19 Era.
N Engl J Med. 2020 May 21;382(21):e63. doi: 10.1056/NEJMp2006372. Epub 2020 Apr 1.
引用本文的文献
1
Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2.
Biomedicines. 2021 Sep 18;9(9):1266. doi: 10.3390/biomedicines9091266.
本文引用的文献
1
Perspectives on Coronavirus Disease 2019 Control Measures for Ophthalmology Clinics Based on a Singapore Center Experience.
JAMA Ophthalmol. 2020 May 1;138(5):435-436. doi: 10.1001/jamaophthalmol.2020.1288.
2
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
4
Efficacy and Safety of Topical Chloroquine in Mild to Moderate Dry Eye Disease.
Curr Eye Res. 2019 Dec;44(12):1306-1312. doi: 10.1080/02713683.2019.1641824. Epub 2019 Jul 15.
5
Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels.
Sci Rep. 2018 Sep 11;8(1):13630. doi: 10.1038/s41598-018-31936-y.
6
Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Am J Ophthalmol. 2018 Oct;194:7-15. doi: 10.1016/j.ajo.2018.05.012. Epub 2018 May 19.
Zotero 插件